Mark J. Cziraky, PharmD, CLS, FAHA
Advertisement
Articles by Mark J. Cziraky, PharmD, CLS, FAHA
Advertisement
Latest Updated Articles
- The Impact of Residual CVD Risk in the Managed Care Setting
March 27th 2009
- Introduction
March 27th 2009
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
3
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
4
Sarcoma Gene Signature May Predict Who Benefits From Pazopanib
5